Markedly elevated serum MMP-9 (Gelatinase B) levels in rheumatoid arthritis: A potentially useful laboratory marker

Clinical Immunology and Immunopathology

Volumn 78, Issue 2, 1996, Pages 161-171

  Gruber, Barry L ^a   Sorbi, Darius ^a   French, Deborah L ^a,b   Marchese, Mary J ^a   Nuovo, Gerard J ^a,b   Kew, Richard R ^a,b   Arbeit, Leonard A ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MESSENGER RNA;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; IMMUNOASSAY; MACROPHAGE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIOCYTE;

EID: 0030007885     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0025     Document Type: Article

References (41)

1. Woessner, J. F. J., Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154, 1991.
2. Hirose, T., Reife, R. A., Smith, G. N., Stevens, R. M., Mainardi, C. L., and Hasty, K. A., Characterization of type-V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. J. Rheumatol. 19, 593-599, 1992.
3. Walakovits, L. A., Moore, V. L., Bhardwaj, N., Gallick, G. S., and Lark, M. W., Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum. 35, 35-42, 1992.
4. Evans, C. H., The role of proteinases in cartilage destruction. Agents Actions 32, 135-152, 1991.
5. Brinckerhoff, C. E., Editorial: Joint destruction in arthritis: Metalloproteinases in the spotlight. Arthritis Rheum. 34, 1073-1075, 1991.
6. Hibbs, M. S., Hasty, K. A., Seyer, J. M., Kang, A. H., and Mainardi, C. L., Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260, 2493-2500, 1985.
7. Hibbs, M. S., Hoidal, J. R., and Kang, A. H., Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J. Clin. Invest. 80, 1644-1650, 1987.
8. Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I., SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264, 17213-17321, 1989.
9. Unemori, E. N., Hibbs, M. S., and Amento, E. P., Constitutive expression of a 92-kDa gelatinase (type-V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J. Clin. Invest. 88, 1656-1662, 1991.
10. Huhtala, P., Tuuttila, A., Chow, L. T., Lohi, J., Keskioja, J., and Tryggvason, K., Complete structure of the human gene for 92-kDa type-IV collagenase: Divergent regulation of expression for the 92-kilodalton and 72-kilodalton enzyme genes in HT-1080 cells. J. Biol. Chem. 266, 16485-16490, 1991.
11. Ogata, Y., Enghild, J. J., and Nagase, H., Matrix metalloproteinase-3 (stromelysin) activates the precursor for the human matrix metalloproteinase-9. J. Biol. Chem. 267, 3581-3584, 1992.
12. Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, T., and Marmer, B. L., Interaction of 92-kDa type IV collagenase with tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.. J. Biol. Chem. 267, 4583-4591, 1992.
13. Arnett, F. C., Edworthy, S., and Block, D. A., et al., The 1987 revised ARA criteria for rheumatoid arthritis. Arthritis Rheum. 30, (Suppl.) 17, 1987.
14. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-684, 1970.
15. Sorbi, D., Fadly, M., Hicks, R., Alexander, S., and Arbeit, L., Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases. Kidney Int. 44, 1266-1272, 1993.
16. Wilkinson, M. J., Cohen, R. L., and Shuman, M. A., A nonradioactive assay for type IV collagen degradation. Anal. Biochem. 185, 294-296, 1990.
17. Ramos-DeSimone, N., Moll, U. M., Quigley, J. P., and French, D. L., Inhibition of matrix metalloproteinase-9 activation by a specific monoclonal antibody. Hybridoma 12, 349-363, 1993.
18. r. 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res. 50, 6162-6170, 1990.
19. Nuovo, G. J., Gallery, F., MacConnell, P., and Braun, A., In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am. J. Pathol. 144, 659-666, 1994.
20. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J., Basic local alignment search tool. J. Mol. Biol. 215, 403-410, 1990.
21. Harris, E. D. J., Rheumatoid arthritis: Pathophysiology and implications for therapy. N. Engl. J. Med. 322, 1277-1289, 1990.
22. Tetlow, L. C., Lees, M., Nagase, H., and Woolley, D. E., Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol Int. 13, 53-59, 1993.
23. Welgus, H. W., Campbell, E. J., Cury, J. D., Eisen, A. Z., Senior, R. M., Wilhelm, S. M., and Goldberg, G. I., Neutral metalloproteinases produced by human mononuclear phagocytes. J. Clin. Invest. 86, 1496-1502, 1990.
24. Opdenakker, G., Masure, S., Grillet, B., and Van Damme, J., Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res. 10, 317-324, 1991.
25. Kalebic, T., Garbisa, S., Glaser, B., and Liotta, L. A., Basement membrane collagen degradation by migrating endothelial cells. Science 221, 281-283, 1983.
26. Schnaper, H. W., Grant, D. S., and Stetler-Stevenson, W. G., et al., Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156, 235-246, 1993.
27. Dean, D. D., Martel-Pelletier, J., Pelletier, J. P., Howell, D. S., and Woessner, J. F. F., Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84, 678-685, 1989.
28. Vartio, T., and Baumann, M., Human gelatinase/type IV collagenase is a regular plasma component. FEBS Lett. 255, 285-289, 1989.
29. Zucker, S., Lysik, R. M., Zarrabi, M. H., and Moll, U., 92-kDa type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 53, 140-146, 1993.
30. Garbisa, S., Scagliotti, G., Masiero, L., DiFrancesco, C., Caenazzo, C., Onisto, M., Micela, M., Stetler-Stevenson, W. G., and Liotta, L. A., Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res. 52, 4548-4549, 1992.
31. Harris, E. D., Excitement in synovium: The rapid evolution of understanding of rheumatoid arthritis and expectations for therapy. J. Rheumatol. 19, 3-6, 1992.
32. Hochberg, M. C., Predicting the prognosis of patients with rheumatoid arthritis: Is there a crystal ball? J. Rheumatol. 20, 1265-1267, 1993.
33. Gordon, J. L., Drummond, A. H., and Galloway, W. A., Metalloproteinase inhibitors as therapeutics. Clin. Exp. Rheumatol. 11, S91-4, 1993.
34. Zucker, S., Mancuso, P., DiMassimo, B., Lysik, R. M., Conner, C., and Chien-Liang, W., Comparison of techniques for measurement of gelatinases/type IV collagenases: Enzyme-linked immunoassays versus substrate degradation assays. Clin. Exp. Metastasis 12, 13-23, 1994.
35. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Marmer, B. L., Grant, G. A., Seltzer, J. L., Kronberger, A., He, C., Bauer, E. A., and Goldberg, G. I., H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 263, 6579-6587, 1988.
36. Carmichael, D. F., Sommer, A., Thompson, R. C., Anderson, D. C., Smith, C. G., Welgus, H. G., and Stricklin, G. P., Primary structure and cDNA cloning of human fibroblast inhibitor. Proc. Natl. Acad. Sci. USA 83, 2407-2411, 1986.
37. Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A. T., and Liotta, L. A., Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265, 13933-13938, 1990.
38. Zucker, S., Lysik, R. M., Zarrabi, M. H., Greenwald, R. A., Gruber, B. L., Tickle, S. P., Baker, T. S., and Docherty, A. J. P., Elevated plasma stromelysin levels in arthritis. J. Rheumatol. 21, 2329-2333, 1994.
39. Clark, I. M., Powell, L. K., Wright, J. K., Cawston, T. E., and Hazleman, B. L., Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase. Matrix 12, 475-480, 1992.
40. Nuovo, G. J., MacConnell, P., Valea, F., and French, D. L., Correlation of the in situ detection of PCR-amplified metalloproteinase cDNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 55, 267-275, 1995.
41. Henson, P. M., Zanolari, B., Schwartzmann, N. A., and Hong, S. R., Intracellular control of human neutrophil secretion: C5a-induced stimulus specific desenstization and the effects of cytochalasin B. J. Immunol. 121, 851-855, 1978.